Prabhakar Pandey, MD
Urology · Goodyear, AZNPI 1861491870
Payments from drug & device makers
Across 167 payments — averaging $36.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Medtronic$822
- Smith+Nephew$703
- Myriad Genetic Laboratories, Inc.$326
- Intuitive Surgical$314
- Axonics, Inc.$273
- plus $2K from 35 others
What the payments were for
- Food & beverage$6,04299%
- Education$541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 32 | $1,550 |
| Medtronic | 16 | $822 |
| Smith+Nephew | 11 | $703 |
| Myriad Genetic Laboratories, Inc. | 10 | $326 |
| Intuitive Surgical | 2 | $314 |
| Axonics, Inc. | 8 | $273 |
| Astellas Pharma US Inc | 9 | $257 |
| Coloplast | 7 | $254 |
| Coopersurgical, Inc. | 3 | $228 |
| Johnson & Johnson(2 entities) | 9 | $194 |
| Ferring Pharmaceuticals Inc. | 7 | $149 |
| Pfizer | 5 | $83 |
| Novartis | 3 | $78 |
| Merck | 3 | $78 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $70 |
| Olympus America Inc. | 4 | $64 |
| Calyxo, Inc. | 3 | $61 |
| Progenics Pharmaceuticals, Inc. | 2 | $55 |
| ABC Home Medical Supply, Inc. | 2 | $39 |
| Endo Pharmaceuticals Inc. | 2 | $37 |
| Caldera Medical, Inc | 2 | $31 |
| Urogen Pharma, Inc. | 2 | $30 |
| Blue Earth Diagnostics | 2 | $27 |
| AbbVie | 1 | $27 |
| Rigel Pharmaceuticals, Inc. | 1 | $26 |
| Endo USA, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Eisai Inc. | 1 | $23 |
| Osiris Therapeutics Inc. | 1 | $22 |
| Accord Healthcare, Inc. | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Amgen | 1 | $20 |
| Cook Medical LLC | 3 | $20 |
| Tolmar, Inc. | 1 | $20 |
| Bayer | 1 | $20 |
| Urovant Sciences Inc | 1 | $19 |
| Immunitybio, Inc. | 1 | $19 |
| Teleflex LLC | 1 | $18 |
| Ambu Inc. | 1 | $17 |
| AVEO Pharmaceuticals, Inc. | 1 | $16 |
| Laborie Medical Technologies Corp. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$480
- Stravix$356
- Da Vinci Surgical System$242
- LithoVue$239
- Prolaris$168
- STRAVIX PL$165
- GENERAL - THERAPIES$161
- GENERAL FEMALE SUI$150
- Moses 550 D\F\L$146
- IMAJIN$146
- GENERAL KIDNEY STONE DISEASE$142
- Axonics$133
- Bulkamid$133
- GENERAL ERECTILE DYSFUNCTION$125
- GREENLIGHT$120
- MYRBETRIQ$115
- Uterine Manipulators & Injectors$107
How this compares
$6,096 in reported general payments places this provider in the 60th percentile of 269 urology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 23 | $14,686 |
| Ciprofloxacin Hcl | 530 | $3,106 |
| Tamsulosin Hcl | 150 | $1,913 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 109 | $917 |
| Estradiol | 14 | $714 |
| Finasteride | 23 | $398 |
| Doxazosin Mesylate | 25 | $318 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $232 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $80 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $257 | $14,68623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 269 urology providers in Arizona.
Other urology in Goodyear
- Shawn BlickGoodyear$336K
- Lipika McCauleyGoodyear$42K
- Paul GellhausGoodyear$40K
- Vi HuaGoodyear$12K
- Curtis DunsheeTucson$16M
- Mark TysonScottsdale$4.9M
- Kalpesh PatelTucson$2.3M
- Susan KalotaTucson$1.2M
- Mitchell HumphreysPhoenix$1.1M
- Donald LammPhoenix$403K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.